Table 3 Risk Factor for the Development of Delayed Graft Function

Donor

 Age

1.00 (0.98-1.02)

0.7

 Male

3.42 (1.60-7.30)

0.002

2.30 (0.83-6.37)

0.1

 BMI

1.08 (0.98-1.18)

0.1

 DM

1.07 (0.34-3.36)

0.9

 Hypertension

1.25 (0.61-2.58)

0.5

 Cause of death (CVA)

1.14 (0.63-2.08)

0.7

 AKI by KDIGO

5.86 (2.37-14.47)

<0.001

6.67 (1.60-27.73)

0.009

 AKI by AKIN

5.95 (2.59-13.65)

<0.001

8.93 (2.46-32.44)

0.001

 CVP

1.08 (0.99-1.17)

0.08

 MAP

1.01 (0.99-1.03)

0.2

 Last day urine output

1.00 (1.00-1.00)

0.6

 Cold ischemic time

1.00 (1.00-1.00)

0.2

Recipient

 Age

0.98 (0.96-1.01)

0.3

 Male

1.07 (0.60-1.93)

0.8

 BMI

1.01 (0.92-1.10)

0.9

 DM

1.03 (0.48-2.22)

0.9

 Hypertension

1.34 (0.53-3.38)

0.5

 GN

1.29 (0.72-2.32)

0.4

 Retransplantation

1.61 (0.67-3.85)

0.3

 PRA

1.01 (1.00-1.02)

0.2

 HLA MN

1.19 (0.91-1.55)

0.2

 ATG (Reference = Basiliximab)

0.83 (0.35-1.98)

0.7

 Tacrolimus (Reference = Cyclosporine)

0.23 (0.13-0.48)

<0.001

0.07 (0.01-1.01)

0.06